Annual report pursuant to Section 13 and 15(d)


$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:    
Net loss $ (4,154) $ (4,965)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 6 5
Stock-based compensation 889 800
Discount amortization of promissory notes 1,197
Revaluation of warrants to purchase Common stock   549
Changes in operating assets and liabilities:    
Trade receivables (71) (18)
Prepaid expenses and other accounts receivable (34) (14)
Inventories (68) (9)
Trade payables 25 86
Other accounts payable (182) 183
Accrued severance pay, net 43 4
Other assets (4)
Net cash used in operating activities (3,550) (2,182)
Cash flows from investment activities:    
Purchase of property and equipment (8)
Net cash used in investment activities (8)
Cash flows from financing activities:    
Proceeds from issuance of Convertible Promissory Notes and warrants   1,380
Proceeds from issuance of Common stock, Preferred D stock and warrants, net of issuance costs 5,056
Proceeds from exercise of Warrants 91
Proceeds from exercise of options 3
Net cash provided by financing activities 94 6,436
Increase (decrease) in cash and cash equivalents (3,466) 4,254
Cash and cash equivalents at the beginning of the year 4,360 106
Cash and cash equivalents at the end of the year 896 4,360
Supplemental information and disclosure of non-cash financing transactions:    
Carve out of warrants' fair value from Convertible Promissory Notes 852
Conversion of convertible notes and accrued interest into Common and Preferred D stock 1,762
Cashless exercise of warrants $ 2,628